20-1537211-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_178460.3(SIRPD):āc.521A>Gā(p.Asn174Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178460.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIRPD | NM_178460.3 | c.521A>G | p.Asn174Ser | missense_variant | 3/4 | ENST00000381623.4 | NP_848555.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIRPD | ENST00000381623.4 | c.521A>G | p.Asn174Ser | missense_variant | 3/4 | 1 | NM_178460.3 | ENSP00000371036.3 | ||
SIRPD | ENST00000381621.5 | c.524A>G | p.Asn175Ser | missense_variant | 3/4 | 3 | ENSP00000371034.1 | |||
SIRPD | ENST00000429387.5 | c.167A>G | p.Asn56Ser | missense_variant | 2/3 | 3 | ENSP00000410072.1 | |||
ENSG00000242324 | ENST00000453770.1 | n.803-3417A>G | intron_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251214Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135742
GnomAD4 exome AF: 0.0000561 AC: 82AN: 1461868Hom.: 0 Cov.: 30 AF XY: 0.0000591 AC XY: 43AN XY: 727236
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2022 | The c.521A>G (p.N174S) alteration is located in exon 3 (coding exon 3) of the SIRPD gene. This alteration results from a A to G substitution at nucleotide position 521, causing the asparagine (N) at amino acid position 174 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at